Cadila Pharmaceuticals on Monday announced the launch of an aqueous formulation of cholecalciferol to treat Vitamin D deficiency. According to the company’s statement, it is the world’s first ...

New Delhi, Mar 11 () Drug firm Cadila Healthcare on Wednesday said its board has approved the transfer of its animal healthcare business on a going concern basis to its wholly-owned arm Zydus ...

Shares of Cadila Healthcare, a listed entity of the Zydus group, ended 3.67 per cent up at Rs 265.40 apiece on the BSE. MSS MRMR ...

With strong growth in domestic and international markets, Cadila continues to be among the top five pharmaceutical companies in India. It has recently acquired two abbreviated new drug ...

Learn about Cadila Healthcare Ltd in Kundaim, Goa.Find comprehensive contact details, including phone numbers and email addresses, and get directions to the location. If you own or are associated ...

Zydus Lifesciences Limited (Formerly known as Cadila Healthcare Limited) is one of the leading innovation driven pharmaceutical companies in India with presence across the pharmaceutical value ...

Cadila Pharmaceuticals on Monday announced the launch of the Cadiflu Tetra Vaccine which is an advanced Quadrivalent Influenza Vaccine to prevent influenza, a recurrent, widespread, and ...

Cadila Healthcare said in a regulatory filing. The antibody cocktail therapy is most suited for high-risk COVID-19 patients within the first 10 days of onset of symptoms and meet any of the listed ...

Learn about Zydus Cadila Healthcare Ltd. in Ahmedabad, Gujarat.Find comprehensive contact details, including phone numbers and email addresses, and get directions to the location. If you own or ...

Zydus Cadila has filed for emergency use approval (EUA) in India of its plasmid DNA-based vaccine for COVID-19, which if given a green light could become the first shot of its type to be cleared ...

As per the licensing agreement, Helperby will take the compound through further clinical trials, approvals and into commercialisation, it added. Advisory Alert: It has come to our attention that ...

Shareholder Return: 3-year average, Sales Growth: 3-year Compounded Annual Growth Rate, Return On Equity: 3-year Return on Equity. With strong growth in domestic and international markets, Cadila ...